Apolipoprotein B-100 (APOB)

The protein contains 4563 amino acids for an estimated molecular weight of 515605 Da.

 

Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor. (updated: April 1, 2015)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  3. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  4. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology.


Interpro domains
Total structural coverage: 0%
Model score: 0
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
Influences plasma concentrations of low density lipoprotein cholesterol<
dbSNP:rs9282603
dbSNP:rs6752026
dbSNP:rs13306198
empty
dbSNP:rs12714225
FHBL1
dbSNP:rs12714214
dbSNP:rs679899
dbSNP:rs12691202
dbSNP:rs1800476
dbSNP:rs12714192
dbSNP:rs12714097
dbSNP:rs13306206
dbSNP:rs12720801
dbSNP:rs12713844
dbSNP:rs12713843
dbSNP:rs1041956
dbSNP:rs13306187
dbSNP:rs568413
dbSNP:rs1801697
dbSNP:rs61742247
dbSNP:rs773681906
dbSNP:rs1801699
dbSNP:rs533617
empty
dbSNP:rs1041960
dbSNP:rs12713681
dbSNP:rs584542
dbSNP:rs1041971
dbSNP:rs12713675
a colorectal cancer sample; somatic mutation; confirmed at protein level
dbSNP:rs1801696
dbSNP:rs1042013
dbSNP:rs676210
dbSNP:rs2163204
dbSNP:rs1801694
dbSNP:rs12720848
dbSNP:rs12720854
dbSNP:rs12720855
dbSNP:rs1042021
dbSNP:rs1042022
dbSNP:rs1042023
FHCL2
FHCL2
dbSNP:rs1801701
dbSNP:rs1042025
dbSNP:rs12713540
dbSNP:rs776119459
dbSNP:rs72654409
dbSNP:rs1801698
dbSNP:rs1042027
dbSNP:rs1126468
dbSNP:rs1801703
dbSNP:rs1042031
dbSNP:rs1801702
dbSNP:rs72654423
dbSNP:rs1042034
dbSNP:rs12720843
dbSNP:rs1801695
dbSNP:rs142702699
dbSNP:rs12713450
Does not affect plasma lipid levels
FHBL1; unknown pathological significance; does not affect interaction with MTTP

The reference OMIM entry for this protein is 107730

Apolipoprotein b; apob apob100, included
Apob48, included
Apolipoprotein b allotypes, included
Ag lipoprotein types, included
Low density lipoprotein cholesterol level quantitative trait locus 4, included; ldlcq4, included

DESCRIPTION

Apolipoprotein B is the main apolipoprotein on chylomicrons and low density lipoproteins (LDLs). It occurs in the plasma in 2 main forms, apoB48 and apoB100. The first is synthesized exclusively by the intestine, the second by the liver (summary by Law et al., 1985).

CLONING

Lusis et al. (1985) identified cDNA clones for rat liver apoB. Law et al. (1985) cloned human APOB. Deeb et al. (1986) found that APOB RNA isolated from monkey small intestine contained sequences homologous to the cDNA of apolipoprotein B100. These results were interpreted as indicating that intestinal (B48) and hepatic (B100) forms of apoB are coded by a single gene. Glickman et al. (1986) found a single mRNA transcript for apoB regardless of the form of apoB (apoB100 or apoB48) synthesized in the liver or intestine. Hospattankar et al. (1986) presented some immunologic data suggesting that the 2 proteins share a common carboxyl region sequence. Chen et al. (1986) determined the complete cDNA and amino acid sequence of apoB100. Knott et al. (1986) reported the primary structure of apolipoprotein B. The precursor has 4,563 amino acids; the mature apoB100 has 4,536 amino acid residues. This represents a very large mRNA of more than 16 kb. Law et al. (1986) also provided the complete nucleotide and derived amino acid sequence of apoB100 from a study of cDNA. Strong evidence that apoB100 and apoB48 are products of the same gene was provided by Young et al. (1986). Cladaras et al. (1986) concluded from the sequence of apolipoprotein B100 that apoB48 may result from differential splicing of the same primary apoB mRNA transcript. Hardman et al. (1987) found that mature, circulating B48 is homologous over its entire length (estimated to be between 2,130 and 2,144 amino acid residues) with the amino-terminal portion of B100 and contains no sequence from the carboxyl end of B100. From structural studies, Innerarity et al. (1987) concluded that apoB48 represents the amino-terminal 47% of apoB100 and that the carboxyl terminus of apoB48 is in the vicinity of residue 2151 of apoB100. Chen et al. (1987) deduced that human apolipoprotein B48 is the product of an intestinal mRNA with an in-frame UAA stop codon resulting from a C-to-U change in the codon CAA encoding Gln(2153) in apoB100 mRNA. The carboxyl-terminal ile-2152 of apoB48 purified from chylous ascites fluid has apparently been cleaved from the initial translation product, leaving met-2151 as the new carboxyl-terminus. The organ-specific introduction of a stop codon to an mRNA is an unprecedented finding. Only the sequence that codes B100 is present in genomic DNA. The change from CAA to UAA as codon 2153 of the message is a unique RNA editing process. Higuchi et al. (1988) reported similar findings. ApoB48 contains 2,152 residues compared to 4,535 residues in apoB100. Using a cloned rat cDNA as a probe, Lau et al. (1994) cloned cDNA and genomic sequences of the gene for the human APOB mRNA editing protein (BEDP; 600130). Expression of the cDNA in HepG2 cells resulted in editing of the intracellular apoB mRNA. By Northern blot analysis, they showed that the human BEDP mRNA is expressed exclusively in the small intestine.

MAPPING

Law et al. (1985) assigned the APOB gene to chromosome 2 by filter hybridization with DNA from human/mouse somatic cell hybrids. By somatic cell hybrid studies and by in situ hybridization, Knott et al. (1985) assigned the APOB gene to the tip of 2p in ... More on the omim web site

Subscribe to this protein entry history

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 107730 was added.